Literature DB >> 18945884

Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population.

Emily G Severance1, Ioannis Bossis, Faith B Dickerson, Cassie R Stallings, Andrea E Origoni, Anne Sullens, Robert H Yolken, Raphael P Viscidi.   

Abstract

Coronaviruses cause respiratory infections ranging from common colds to severe acute respiratory syndrome (SARS) in humans. Estimates for exposure to non-SARS coronaviruses are high, particularly for 229E and OC43; however, less information regarding seroprevalence is available for HKU1 and NL63. To measure exposure rates to these four coronavirus strains (229E, HKU1, NL63, and OC43), we devised an immunoassay based on amino- and carboxy-terminally tagged recombinant coronavirus nucleocapsid antigens. Four human and one feline coronavirus antigen were cloned into baculoviruses expressed in insect cells and recovered proteins bound in the solid phase of an enzyme-linked immunosorbent assay-based system. We screened sera from 10 children and 196 adults and established primary cutoff points based on immunoglobulin G (IgG) antibody levels of the predominantly seronegative children. The proportion of seropositive adults for each coronavirus was as follows: 229E, 91.3%; HKU1, 59.2%; NL63, 91.8%; and OC43, 90.8%. No evidence of a significant serological response to the feline coronavirus was observed. Significant associations of coronavirus seropositivity and antibody levels with age, gender, race, socioeconomic status, smoking status, and season of the blood draw were tested with chi-square and regression analyses. The group II coronaviruses (OC43 and HKU1) were significantly associated with race (P<or=0.009 and P<or=0.03, respectively). Elevated OC43 IgG levels were further significantly associated with smoking status (P<or=0.03), as were high NL63 titers with socioeconomic status (P<or=0.04). The high-level immunoreactivity of each coronavirus was significantly associated with the summer season (P<or=0.01 to 0.0001). In summary, high rates of exposure to 229E, NL63, and OC43 and a moderate rate of exposure to HKU1 characterized the seroprevalence among individuals in this population. Demographic factors, such as race, smoking status, and socioeconomic status, may confer an increased risk of susceptibility to these viruses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945884      PMCID: PMC2593164          DOI: 10.1128/CVI.00124-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  21 in total

Review 1.  The novel human coronaviruses NL63 and HKU1.

Authors:  Krzysztof Pyrc; Ben Berkhout; Lia van der Hoek
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

2.  Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia.

Authors:  Patrick C Y Woo; Susanna K P Lau; Chung-ming Chu; Kwok-hung Chan; Hoi-wah Tsoi; Yi Huang; Beatrice H L Wong; Rosana W S Poon; James J Cai; Wei-kwang Luk; Leo L M Poon; Samson S Y Wong; Yi Guan; J S Malik Peiris; Kwok-yung Yuen
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.

Authors:  K McIntosh; J H Dees; W B Becker; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1967-04       Impact factor: 11.205

4.  A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology.

Authors:  P Sehr; K Zumbach; M Pawlita
Journal:  J Immunol Methods       Date:  2001-07-01       Impact factor: 2.303

5.  Antibodies to human coronaviruses 229E and OC43 in the population of C.R.

Authors:  J Hrusková; F Heinz; E Svandová; S Pennigerová
Journal:  Acta Virol       Date:  1990-08       Impact factor: 1.162

Review 6.  Human coronaviruses: what do they cause?

Authors:  Lia van der Hoek
Journal:  Antivir Ther       Date:  2007

7.  Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.

Authors:  Faith B Dickerson; John J Boronow; Cassie Stallings; Andrea E Origoni; Sara Cole; Bogdana Krivogorsky; Robert H Yolken
Journal:  Biol Psychiatry       Date:  2004-03-15       Impact factor: 13.382

8.  Rises in titers of antibody to human coronaviruses OC43 and 229E in Seattle families during 1975-1979.

Authors:  O W Schmidt; I D Allan; M K Cooney; H M Foy; J P Fox
Journal:  Am J Epidemiol       Date:  1986-05       Impact factor: 4.897

9.  Seroepidemiology of group I human coronaviruses in children.

Authors:  Xiuping Shao; Xiaojie Guo; Frank Esper; Carla Weibel; Jeffrey S Kahn
Journal:  J Clin Virol       Date:  2007-09-21       Impact factor: 3.168

10.  Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43.

Authors:  Thomas Mourez; Astrid Vabret; Yang Han; Julia Dina; Loïc Legrand; Sandrine Corbet; François Freymuth
Journal:  J Virol Methods       Date:  2006-10-31       Impact factor: 2.014

View more
  47 in total

1.  Kinetics of viral load and antibody response in relation to COVID-19 severity.

Authors:  Yanqun Wang; Lu Zhang; Ling Sang; Feng Ye; Shicong Ruan; Bei Zhong; Tie Song; Abeer N Alshukairi; Rongchang Chen; Zhaoyong Zhang; Mian Gan; Airu Zhu; Yongbo Huang; Ling Luo; Chris Ka Pun Mok; Manal M Al Gethamy; Haitao Tan; Zhengtu Li; Xiaofang Huang; Fang Li; Jing Sun; Yanjun Zhang; Liyan Wen; Yuming Li; Zhao Chen; Zhen Zhuang; Jianfen Zhuo; Chunke Chen; Lijun Kuang; Junxiang Wang; Huibin Lv; Yongliang Jiang; Min Li; Yimin Lin; Ying Deng; Lan Tang; Jieling Liang; Jicheng Huang; Stanley Perlman; Nanshan Zhong; Jingxian Zhao; J S Malik Peiris; Yimin Li; Jincun Zhao
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 2.  Is innate immunity our best weapon for flattening the curve?

Authors:  Leonard Angka; Marisa Market; Michele Ardolino; Rebecca C Auer
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

3.  Isolation, propagation, genome analysis and epidemiology of HKU1 betacoronaviruses.

Authors:  Samuel R Dominguez; Susmita Shrivastava; Andrew Berglund; Zhaohui Qian; Luiz Gustavo Bentim Góes; Rebecca A Halpin; Nadia Fedorova; Amy Ransier; Philip A Weston; Edison Luiz Durigon; José Antonio Jerez; Christine C Robinson; Christopher D Town; Kathryn V Holmes
Journal:  J Gen Virol       Date:  2014-01-06       Impact factor: 3.891

4.  Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies.

Authors:  Patricia Sastre; Ronald Dijkman; Ana Camuñas; Tamara Ruiz; Maarten F Jebbink; Lia van der Hoek; Carmen Vela; Paloma Rueda
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

5.  Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum.

Authors:  Geoffrey J Gorse; Gira B Patel; Joseph N Vitale; Theresa Z O'Connor
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

6.  Infection of human alveolar macrophages by human coronavirus strain 229E.

Authors:  C Joel Funk; Jieru Wang; Yoko Ito; Emily A Travanty; Dennis R Voelker; Kathryn V Holmes; Robert J Mason
Journal:  J Gen Virol       Date:  2011-11-16       Impact factor: 3.891

7.  Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2.

Authors:  Bezawit A Woldemeskel; Abena K Kwaa; Caroline C Garliss; Oliver Laeyendecker; Stuart C Ray; Joel N Blankson
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

8.  Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.

Authors:  Kuan-Ying A Huang; Tiong Kit Tan; Ting-Hua Chen; Chung-Guei Huang; Ruth Harvey; Saira Hussain; Cheng-Pin Chen; Adam Harding; Javier Gilbert-Jaramillo; Xu Liu; Michael Knight; Lisa Schimanski; Shin-Ru Shih; Yi-Chun Lin; Chien-Yu Cheng; Shu-Hsing Cheng; Yhu-Chering Huang; Tzou-Yien Lin; Jia-Tsrong Jan; Che Ma; William James; Rodney S Daniels; John W McCauley; Pramila Rijal; Alain R Townsend
Journal:  PLoS Pathog       Date:  2021-02-26       Impact factor: 6.823

9.  Sero-epidemiology of human coronaviruses in three rural communities in Ghana.

Authors:  Michael Owusu; Augustina Angelina Sylverken; Philip El-Duah; Godfred Acheampong; Mohammed Mutocheluh; Yaw Adu-Sarkodie
Journal:  Pan Afr Med J       Date:  2021-03-08

10.  Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms.

Authors:  Emily G Severance; Faith B Dickerson; Raphael P Viscidi; Ioannis Bossis; Cassie R Stallings; Andrea E Origoni; Anne Sullens; Robert H Yolken
Journal:  Schizophr Bull       Date:  2009-06-02       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.